arrow
Back
B

Brent A. Neuschwander‐Tetri

Saint Louis University

85H-index
309Paper Count
4.7WCitation Count
Published Papers 151
Publication Date
The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease
err2026-06-23
err0
errOAAI
errMohammad S. Siddiqui; Mark L. Van Natta; Margery A. Connelly; Jeanne Clark; Brent A. Neuschwander-Tetri; Anna Mae Diehl; Srinivasan Dasarathy; Rohit Loomba; Naga Chalasani; Kris V. Kowdley; Bilal Hameed; Laura A. Wilson; Katherine P. Yates; Patricia Belt; David E. Kleiner; Cynthia Behling; James Tonascia; Arun J. Sanyal
errShare
errSave
A reasonably likely surrogate endpoint for metabolic dysfunction–associated steatohepatitis
err2026-04-28
err0
PREAI
errArun J. Sanyal; Michelle T. Long; Nancy Obuchowski; Roberto A. Calle; Raj Vuppalanchi; Brent Neuschwander-Tetri; Rohit Loomba; Katherine Yates; Patricia Grebenstein; Melissa A. Jones; Tania N. Kamphaus
errShare
errSave
Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
err2026-03-01
err6
PREAI
errBarritt, A. Sidney; Tapper, Elliot B.; Newsome, Philip N.; Gazis, Derek; Morris, Heather; Mospan, Andrea R.; Perez, Anthony Daniel; Kim, Yestle; Neuschwander-Tetri, Brent A.; Loomba, Rohit; Sanyal, Arun
errShare
errSave
Clinically distinct metabotypes of pediatric MASLD identified through unsupervised clustering of NASH CRN data
err2026-02-24
err0
errOAAI
errHelaina E. Huneault; Pradeep Tiwari; Zachery R. Jarrell; Matthew Ryan Smith; Chih-Yu Chen; Ana Ramirez Tovar; Cristian Sanchez-Torres; Scott Gillespie; Shasha Bai; Rodrigo M. Carrillo-Larco; Ajay K. Jain; Katherine P. Yates; Brent A. Neuschwander-Tetri; Jeffrey B. Schwimmer; Stavra A. Xanthakos; Jean P. Molleston; Cynthia A. Behling; Mark H. Fishbein; Terryl J. Hartman; Francisco J. Pasquel; Rishikesan Kamaleswaran; Dean P. Jones; Jean A. Welsh; Miriam B. Vos
errShare
errSave
Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLD
err2026-02-11
err0
PREAI
errMatthew Dukewich; Laura A. Wilson; Jennifer L. Dodge; Liyun Yuan; Bilal Hameed; Katherine P. Yates; Rohit Loomba; Brent A. Neuschwander-Tetri; Wendy Mack; Norah Terrault
errShare
errSave
Evaluation of Pathogenic Variants Associated With Monogenic Disorders of Dyslipidemia in Patients With Well Characterised MASLD
err2026-01-09
err0
errOAAI
errSchwantes-an, Tae-hwi; Abreu, Marco A.; Neuschwander-tetri, Brent A.; Wang, Jian; Guo, Xiuqing; Tan, Jingyi; Hegele, Robert A.; Davidson, Nicholas O.; Lotta, Luca; Verweij, Niek; Yates, Katherine P.; Rotter, Jerome I.; Chalasani, Naga
errShare
errSave
Association of Components of Metabolic Syndrome and the Progression of Nonalcoholic Fatty Liver Disease
err2026-01-01
err3
PREAI
errLe, Phuc; Tatar, Moosa; Rothberg, Michael B.; Wilson, Laura A.; Allende, Daniela; Diehl, Anna Mae; Loomba, Rohit; Chalasani, Naga; Neuschwander-Tetri, Brent A.; Kowdley, Kris; Sanyal, Arun J.; Tonascia, James; Dasarathy, Srinivasan
errShare
errSave
Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network
err2025-12-01
err0
PREAI
errSohal, Aalam; Wilson, Laura A.; Kleiner, David E.; Loomba, Rohit; Yuan, Liyun; Dasarathy, Srinivasan; Sanyal, Arun J.; Neuschwander-Tetri, Brent A.; Chalasani, Naga P.; Diehl, Anna Mae; Kowdley, Kris V.
errShare
errSave
errShare
errSave
The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH
err2025-07-16
err0
PREAI
errBrent A. Neuschwander-Tetri; Heather L. Morris; Andrea R. Mospan; Feng Yu; Breda Munoz; Sheenu Abraham; Michael W. Fried; A. Sidney Barritt IV
errShare
errSave
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease
err2025-05-02
err0
PREAI
errSingal, AK; Wong, RJ; Dasarathy, S; Abdelmalek, MF; Neuschwander-Tetri, BA; Limketkai, BN; Petrey, J; Mcclain, CJ
errShare
errSave
The emerging role of second harmonic generation/two photon excitation for precision digital analysis of liver fibrosis in MASH clinical trials
err2025-04-30
err0
PREAI
errBrent A. Neuschwander-Tetri; Kutbuddin Akbary; Danielle H. Carpenter; Mazen Noureddin; Naim Alkhouri
errShare
errSave
Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD
err2024-10-01
err2
PREAI
errGawrieh, Samer; Vilar-Gomez, Eduardo; Wilson, Laura A.; Pike, Francis; Kleiner, David E.; Neuschwander-Tetri, Brent A.; Diehl, Anna Mae; Dasarathy, Srinivasan; Kowdley, Kris V.; Hameed, Bilal; Tonascia, James; Loomba, Rohit; Sanyal, Arun J.; Chalasani, Naga
errShare
errSave
Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulation
err2024-09-12
err0
PREAI
errSuri, Anandini; Zhang, Zidong; Neuschwander-Tetri, Brent; Lomas, David A.; Heyer-Chauhan, Nina; Burling, Keith; Loomba, Rohit; Brenner, David A.; Nagy, Rosemary; Wilson, Andrew; Carpenter, Danielle; Blomenkamp, Keith; Teckman, Jeffrey
errShare
errSave
Liver stiffness progression in biopsy-proven metabolic dysfunction-associated steatotic disease among people with diabetes versus people without diabetes: A prospective multicenter study
err2024-07-19
err2
PREAI
errHuang, Daniel Q.; Wilson, Laura A.; Behling, Cynthia; Amangurbanova, Maral; Kleiner, David E.; Kowdley, Kris V.; Dasarathy, Srinivasan; Terrault, Norah A.; Diehl, Anna Mae; Chalasani, Naga; Neuschwander-Tetri, Brent A.; Sanyal, Arun J.; Tonascia, James; Loomba, Rohit
errShare
errSave
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLD
err2024-05-01
err2
PREAI
errJarasvaraparn, Chaowapong; Vilar-Gomez, Eduardo; Yates, Katherine P.; Wilson, Laura A.; Neuschwander-Tetri, Brent; Loomba, Rohit; Cummings, Oscar; Vos, Miriam; Xanthakos, Stavra; Schwimmer, Jeffrey; Molleston, Jean P.; Sanyal, Arun; Tonascia, James; Chalasani, Naga
errShare
errSave
PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease
err2024-04-23
err3
PREAI
errChalasani, Naga; Vilar-Gomez, Eduardo; Loomba, Rohit; Yates, Katherine P.; Diehl, Anna Mae; Neuschwander-Tetri, Brent A.; Dasarathy, Srinivasan; Kowdley, Kris V.; Terrault, Norah; Wilson, Laura A.; Tonascia, James; Sanyal, Arun J.
errShare
errSave
High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort
err2024-04-08
err5
PREAI
errBarritt IV, A. Sidney; Yu, Feng; Mospan, Andrea R.; Newsome, Phillip N.; Roden, Michael; Morris, Heather L.; Loomba, Rohit; Neuschwander-Tetri, Brent A.
errShare
errSave
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study
err2024-01-01
err28
errOAAI
errLoomba, Rohit; Sanyal, Arun J.; Nakajima, Atsushi; Neuschwander-Tetri, Brent A.; Goodman, Zachary D.; Harrison, Stephen A.; Lawitz, Eric J.; Gunn, Nadege; Imajo, Kento; Ravendhran, Natarajan; Akahane, Takemi; Boone, Bradly; Yamaguchi, Masayuki; Chatterjee, Arkendu; Tirucherai, Giridhar S.; Shevell, Diane E.; Du, Shuyan; Charles, Edgar D.; Abdelmalek, Manal F.
errShare
errSave
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study
err2024-01-01
err23
errOAAI
errAbdelmalek, Manal F.; Sanyal, Arun J.; Nakajima, Atsushi; Neuschwander-Tetri, Brent A.; Goodman, Zachary D.; Lawitz, Eric J.; Harrison, Stephen A.; Jacobson, Ira M.; Imajo, Kento; Gunn, Nadege; Halegoua-DeMarzio, Dina; Akahane, Takemi; Boone, Bradly; Yamaguchi, Masayuki; Chatterjee, Arkendu; Du, Shuyan; Tirucherai, Giridhar S.; Shevell, Diane E.; Charles, Edgar D.; Loomba, Rohit
errShare
errSave